doi: 10.1530/eje.0.1490187 106 DoknicMPekicSZarkovicMMedic-StojanoskaMDieguezCCasanuevaFet al
The results demonstrated that the combined regimen significantly improved tinnitus-related scores and TCM syndrome integrals, enhanced hemorheological conditions, and reduced oxidative stress and inflammatory markers compared to cobamamide alone
How to Clinically Use Glucagon-like Peptide-1 Receptor Agonists Current Recommendations Both the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) recommend the use of a GLP-1RA with proven benefit in patients with established CVD or with multiple CV risk factors to reduce MACE, independent of the baseline HbA1c [49]
Berryman DE, Glad CAM, List EO, Johannsson G
Preclinical and clinical data suggest that GLP-1 signaling can downregulate pro-inflammatory cytokines, such as TNF- and IL-6, inhibit NF-Bmediated inflammatory cascades, and reduce oxidative stress
3.4 What Do the Guidelines Say